(Nasdaq: MIRM), a leading rare disease company, today announced completion of enrollment in the Phase 3 AZURE-1 study and completion of screening in the Phase 3 AZURE-4 study, both evaluating ...

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

Researchers at the University of São Paulo (USP) in Brazil have discovered a set of genes that can predict how viral hepatitis may progress in the body. They call this network of genes the ...

Scientists engineered a stabilized, native-like E1E2 glycoprotein complex from hepatitis C virus and incorporated it into a nanoparticle vaccine platform. The approach overcomes a decades-long ...

Hepatitis C virus (HCV) infects an estimated 50 million people worldwide, according to the World Health Organization, and remains a leading cause of cirrhosis and liver cancer. While antiviral drugs ...

Hepatitis C virus (HCV) infects an estimated 50 million people worldwide, according to the World Health Organization, and remains a ...

Liver enzymes help break down food and turn it into energy and nutritional elements, among other things. Elevated levels ...

At CROI 2026, experts warned that missing HBV screening risks reactivation during HIV therapy switches.

One or more additional single dose cohorts planned to further optimize antiviral response and dosing frequency with results expected in the second half of 2020 Conference call and webcast scheduled ...

"Our findings taken with the previously reported BEe-HIVe trial results support reassessing serologies and offering a cytosine phosphoguanine (CpG)-adjuvanted vaccine series to individuals without ...

Credit: Getty Images This patient fact sheet highlights the clinical difference between hepatitis B and C, including transmission, risk factors, screening, and treatment. Our easy-to-read fact sheets ...